DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

Circulation: Heart Failure

JANUARY 26, 2024

Circulation: Heart Failure, Ahead of Print. Patients who underwent bariatric surgery were matched to controls in a 1:2 ratio (matched on exact age, sex, race, body mass index, HF encounter year, and HF hospitalization rate pre-surgery/matched period).

Heart Failure 40

Heart Failure Obesity Outcomes Medicare 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Study Population includes all patients with an ischemic stroke inpatient admission in 2018 and were continuously enrolled with Medicare FFS for 1 year prior to and following their initial 2018 stroke admission. 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient

Risk Factors 40

Risk Factors Strokes Stroke Medicare 40

Frontiers in Cardiovascular Medicine

NOVEMBER 24, 2024

IntroductionHeart failure (HF) burdens the US healthcare system, with annual costs exceeding $30 billion. Outpatient intravenous (OP IV) diuresis in clinic or home settings may potentially improve outcomes and reduce costs, though limited data exists. male, and 74.8% NYHA III-IV. respectively).

Outpatient 59

Outpatient Heart Failure Medicare Inpatient 59